About PCI Pharma Services
PCI Pharma Services is a company based in Philadelphia (United States) founded in 1997. It operates as a Professional Services. PCI Pharma Services has completed 10 acquisitions, including Ajinomoto Bio-Pharma, AndersonBrecon and Bellwyck. PCI Pharma Services offers products and services including Development & Manufacturing, Clinical Trial Services, Advanced Drug Delivery, Commercial Packaging, and Speed Solutions. PCI Pharma Services operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Mubadala
& 4 more
-
Employee Count
Not available
-
Investments & Acquisitions
Ajinomoto Bio-Pharma
& 9 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PCI Pharma Services
PCI Pharma Services offers a comprehensive portfolio of products and services, including Development & Manufacturing, Clinical Trial Services, Advanced Drug Delivery, Commercial Packaging, and Speed Solutions.
Services for drug development and manufacturing are provided.
Support for clinical trials is offered to clients.
Innovative drug delivery solutions are developed for clients.
Packaging solutions for commercial drugs are provided here.
Accelerated drug development services are offered to clients.
People of PCI Pharma Services
Unlock access to complete
Software Development Team
141 people
Senior Team
72 people
Sales and Marketing
60 people
Leadership Team
38 people
Clinical Team
30 people
Finance and Accounting
27 people
Operations Team
24 people
Product Management Team
23 people
Unlock access to complete
Funding Insights of PCI Pharma Services
Investors in PCI Pharma Services
PCI Pharma Services has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Mubadala, Bain Capital Private Equity and Frazier Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward traditional industries.
|
Locked | Locked | Locked | |
|
Healthcare sector private equity investments are managed by the firm.
|
Locked | Locked | Locked | |
|
Private investment firm managing assets and expanding into equity, credit, and real estate services.
|
Locked | Locked | Locked |
Investor details for PCI Pharma Services
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PCI Pharma Services
PCI Pharma Services has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Ajinomoto Bio-Pharma, AndersonBrecon and Bellwyck.
Investment portfolio details for PCI Pharma Services
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small and large molecules are developed and manufactured.
|
Locked | Locked | 2018 | Locked | |
|
Provider of packaging & pharma and healthcare solutions
|
Locked | Locked | 2012 | Locked | |
|
Clinical trial packaging, labeling, and cold chain services are provided.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for PCI Pharma Services
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - PCI Pharma Services
Detailed financials for PCI Pharma Services
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pci Pharma Services Comparisons
Peer comparison for PCI Pharma Services
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PCI Pharma Services
PCI Pharma Services operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of PCI Pharma Services
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pci Pharma Services
Complete news archive for PCI Pharma Services
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PCI Pharma Services
PCI Pharma Services was founded in 1997 and raised its 1st funding round 15 years after it was founded.
PCI Pharma Services is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Salim Haffar is the current CEO of PCI Pharma Services.
PCI Pharma Services is involved in offering comprehensive pharmaceutical services ranging from early-stage drug development to commercialization. The company operates in the healthcare sector, focusing on contract development and manufacturing. Solutions provided include clinical trial services, advanced drug delivery, commercial packaging, and speed solutions for accelerated development. With over five decades of experience, more than 90 successful product launches annually, and a global presence through 30 GMP facilities, the organization supports clients in delivering life-changing therapies.
PCI Pharma Services's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
PCI Pharma Services offers Development & Manufacturing, Clinical Trial Services, Advanced Drug Delivery, Commercial Packaging, and Speed Solutions.
PCI Pharma Services has made 10 acquisitions, including Ajinomoto Bio-Pharma, AndersonBrecon, and Bellwyck.
PCI Pharma Services has 5 investors. Key investors include Mubadala, Bain Capital Private Equity, Frazier Healthcare Partners, Thomas H Lee Partners, and Kohlberg & Company.